Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and cefmetazole

carbapenems has been researched along with cefmetazole in 6 studies

Compound Research Comparison

Studies
(carbapenems)		Trials
(carbapenems)		Recent Studies (post-2010)
(carbapenems)		Studies
(cefmetazole)		Trials
(cefmetazole)		Recent Studies (post-2010) (cefmetazole)
7,3551475,2774066061

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)cefmetazole (IC50)
Insulin-degrading enzymeHomo sapiens (human)7

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Hopkins, JA; Lami, JL; Wilson, SE1
Chang, LY; Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Wang, CY; Wu, TZ; Yang, CY1
Doi, A; Harada, S; Iwata, K; Kamiya, T; Shimada, T1
Hiraki, K; Murakami, N; Sugawara, T; Uetake, N1
Fukuchi, T; Iwata, K; Kobayashi, S; Nakamura, T; Ohji, G1
Enoki, Y; Hayashi, M; Igarashi, Y; Kojima, N; Liu, X; Matsumoto, K; Mizukami, Y; Morita, T; Nakamura, T; Taguchi, K; Takemura, W; Tashiro, S; Yokoyama, Y1

Trials

1 trial(s) available for carbapenems and cefmetazole

ArticleYear
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
    The American surgeon, 1991, Volume: 57, Issue:12

    Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins

1991

Other Studies

5 other study(ies) available for carbapenems and cefmetazole

ArticleYear
Infections of cefotaxime-resistant and cefmetazole-susceptible Escherichia coli and Klebsiella pneumoniae in children.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2005, Volume: 38, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization; Cefmetazole; Cefotaxime; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Heart Defects, Congenital; Humans; Immunologic Deficiency Syndromes; Infant; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Neoplasms; Premature Birth; Taiwan

2005
The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013, Volume: 17, Issue:3

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefmetazole; Culture Media; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Pyelonephritis; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Urine

2013
[Evaluation of Antibiotics for the Treatment of Bacteremia Due to Extended-spectrum β-Lactamase-producing Escherichia coli].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2015, Volume: 135, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefmetazole; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk; Treatment Outcome; Young Adult

2015
Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems.
    BMC infectious diseases, 2016, 08-18, Volume: 16, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefmetazole; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Female; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Urinary Tract Infections

2016
Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments.
    Pharmaceutical research, 2021, Volume: 38, Issue:11

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefmetazole; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Mice; Microbial Sensitivity Tests; Neutropenia

2021